Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc Share Price

$142.47 1.2  0.9%

Last Trade - 7:57pm

Large Cap
Market Cap £13.22bn
Enterprise Value £15.77bn
Revenue £7.92bn
Position in Universe 651st / 7015
Unlock DGX Revenue
Relative Strength (%)
1m +3.72%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.09%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
7,493 7,515 7,402 7,531 7,726 9,437 9,668 8,706 +4.7%
-12.2 +23.9 +20.4 +12.5 +12.9 +68.8 -0.57 -26.2
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2021, QuestDiagnostics Inc revenues increased 44% to $5.27B. Netincome applicable to common stockholders increased from$283M to $1.1B. Revenues reflect DIS Business segmentincrease of 46% to $5.12B, All other operating segmentsincrease of 9% to $153M. Net income benefited from DISBusiness segment income increase from $485M to $1.31B, Allother operating segments income increase of 38% to $18M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for DGX
Graphical History


DGX Revenue Unlock DGX Revenue

Net Income

DGX Net Income Unlock DGX Revenue

Normalised EPS

DGX Normalised EPS Unlock DGX Revenue

PE Ratio Range

DGX PE Ratio Range Unlock DGX Revenue

Dividend Yield Range

DGX Dividend Yield Range Unlock DGX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DGX EPS Forecasts Unlock DGX Revenue
Profile Summary

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Last Annual December 31st, 2020
Last Interim June 30th, 2021
Incorporated September 20, 1996
Public Since December 17, 1996
No. of Shareholders: 2,500
No. of Employees: 40,000
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 130,638,109
Free Float (0.0%)
Eligible for
DGX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for DGX
Upcoming Events for DGX
Wednesday 20th October, 2021 Estimate
Q3 2021 Quest Diagnostics Inc Earnings Release
Frequently Asked Questions for Quest Diagnostics Inc
What is the Quest Diagnostics Inc share price?

As of 7:57pm, shares in Quest Diagnostics Inc are trading at $142.47, giving the company a market capitalisation of £13.22bn. This share price information is delayed by 15 minutes.

How has the Quest Diagnostics Inc share price performed this year?

Shares in Quest Diagnostics Inc are currently trading at $142.47 and the price has moved by 11.92% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Quest Diagnostics Inc price has moved by -17.44% over the past year.

What are the analyst and broker recommendations for Quest Diagnostics Inc?

Of the analysts with advisory recommendations for Quest Diagnostics Inc, there are there are currently 5 "buy" , 7 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Quest Diagnostics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Quest Diagnostics Inc next release its financial results?

Quest Diagnostics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Quest Diagnostics Inc dividend yield?

The Quest Diagnostics Inc dividend yield is 1.63% based on the trailing twelve month period.

Does Quest Diagnostics Inc pay a dividend?

Last year, Quest Diagnostics Inc paid a total dividend of 2.3, and it currently has a trailing dividend yield of 1.63%. Looking ahead, Quest Diagnostics Inc has not announced an ex-dividend date yet.

When does Quest Diagnostics Inc next pay dividends?

Quest Diagnostics Inc has yet to annouce their ex-dividend date. The historic dividend yield on Quest Diagnostics Inc shares is currently 1.63%.

How do I buy Quest Diagnostics Inc shares?

To buy shares in Quest Diagnostics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Quest Diagnostics Inc?

Shares in Quest Diagnostics Inc are currently trading at $142.47, giving the company a market capitalisation of £13.22bn.

Where are Quest Diagnostics Inc shares listed? Where are Quest Diagnostics Inc shares listed?

Here are the trading details for Quest Diagnostics Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: DGX
What kind of share is Quest Diagnostics Inc?

Based on an overall assessment of its quality, value and momentum, Quest Diagnostics Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Quest Diagnostics Inc share price forecast 2021?

Shares in Quest Diagnostics Inc are currently priced at $142.47. At that level they are trading at 4.36% discount to the analyst consensus target price of 0.00.

Analysts covering Quest Diagnostics Inc currently have a consensus Earnings Per Share (EPS) forecast of 11.159 for the next financial year.

How can I tell whether the Quest Diagnostics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Quest Diagnostics Inc. Over the past six months, the relative strength of its shares against the market has been -6.22%. At the current price of $142.47, shares in Quest Diagnostics Inc are trading at 11.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Quest Diagnostics Inc PE Ratio?

The Quest Diagnostics Inc PE ratio based on its reported earnings over the past 12 months is 7.98. The shares are currently trading at $142.47.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Quest Diagnostics Inc?

Quest Diagnostics Inc's management team is headed by:

Michael Prevoznik - SVP
Catherine Doherty - SVP
Gary Pfeiffer - IND
Stephen Rusckowski - CHM
James Davis - EVP
Mark Guinan - CFO
Timothy Main - IND
Vicky Gregg - IND
Carrie Manner - SVP
Denise Morrison - IND
Wright Lassiter - IND
Who are the major shareholders of Quest Diagnostics Inc?

Here are the top five shareholders of Quest Diagnostics Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 11.71% (14.3m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.94% (7.25m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.96% (6.06m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 3.02% (3.69m shares)
Fiduciary Management, Inc. Investment Advisor
Percentage owned: 2.88% (3.51m shares)
Similar to DGX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.